Griffin Securities Initiates Research Coverage on Oragenics, Inc.

Published: Nov 28, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN) ( today announced that Griffin Securities, Inc. has initiated research coverage on the company with a BUY rating and a 12-month target price of $5.00 per share. For more information, please see the full initiation report here.

Back to news